首页> 美国卫生研究院文献>Environmental Health Perspectives >Formation of DNA adducts and induction of mutations in rats treated with tumorigenic doses of 16-dinitropyrene.
【2h】

Formation of DNA adducts and induction of mutations in rats treated with tumorigenic doses of 16-dinitropyrene.

机译:用致瘤剂量的16-二硝基py处理的大鼠中DNA加合物的形成和突变的诱导。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1,6-Dinitropyrene, a component of diesel exhaust, is a lung carcinogen in male F344 rats following a single intrapulmonary administration. In this study, rats were treated with tumorigenic doses of 1,6-dinitropyrene to establish dose-response relationships for the formation of DNA adducts in target (lung) and nontarget (liver) tissues and for the induction of 6-thioguanine-resistant mutations in spleen T-lymphocytes. One week after treatment with 0.3, 1, 3, 10, 30, 100, or 150 micrograms of 1,6-dinitropyrene, dose-responsive DNA binding was measured in lung and liver with binding in the lung being 10-fold higher than in the liver. In the lung, a 2-fold increase in dose resulted in a 1.8-fold increase in DNA binding at treatments up to 30 micrograms of 1,6-dinitropyrene, while in the liver, a 2-fold increase in 1,6-dinitropyrene produced a 2-fold increase in DNA binding at doses up to the 10 micrograms treatment. Higher doses of 1,6-dinitropyrene resulted in proportionally smaller increases in adduct formation in the two tissues. When measured 21 weeks after treatment, mutations in T-lymphocytes increased with doses up to 100 micrograms of 1,6-dinitropyrene, but the response was nonlinear throughout the dose range. These findings indicate that concentrations of 1,6-dinitropyrene that produce a dose-dependent induction of lung tumors also result in a dose-dependent formation of DNA adducts and induction of lymphocyte mutations but that the dose-response curves for DNA binding and mutations are different.
机译:1,6-二硝基py是柴油机尾气中的一种成分,是单次肺内给药后在雄性F344大鼠中的一种肺致癌物。在这项研究中,用致瘤剂量的1,6-二硝基py处理大鼠,以建立剂量-反应关系,以在靶(肺)组织和非靶(肝)组织中形成DNA加合物,并诱导6-硫代鸟嘌呤抗性突变在脾T淋巴细胞中用0.3、1、3、10、30、100或150微克1,6-二硝基py治疗一周后,在肺和肝中测量到剂量反应性DNA结合,与肺中的结合比在肺中高10倍。肝脏。在肺部,剂量增加2倍导致在治疗至多30微克1,6-二硝基py时DNA结合增加1.8倍,而在肝脏中,1,6-二硝基py增加2倍剂量高达10微克时,DNA结合力增加了2倍。较高剂量的1,6-二硝基py导致两个组织中加合物形成的增加成比例地较小。当在治疗后21周进行测量时,剂量高达100微克的1,6-二硝基py,T淋巴细胞的突变会增加,但在整个剂量范围内,其反应都是非线性的。这些发现表明,产生肺肿瘤剂量依赖性诱导的1,6-二硝基py浓度也导致DNA加合物的剂量依赖性形成和淋巴细胞突变的诱导,但是DNA结合和突变的剂量反应曲线为不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号